# An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

> **NCT00403481** · PHASE4 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 192 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** olmesartan medoxomil
- **DRUG:** Olmesartan medoxomil plus Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00403481
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-11
- **Final completion:** 2007-12
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2016-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00403481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00403481, "An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00403481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*